93 related articles for article (PubMed ID: 23564783)
1. Thrombospondin-1 receptor mediates autophagy of RAS-expressing cancer cells and triggers tumour growth inhibition.
Kalas W; Swiderek E; Switalska M; Wietrzyk J; Rak J; Strzadala L
Anticancer Res; 2013 Apr; 33(4):1429-38. PubMed ID: 23564783
[TBL] [Abstract][Full Text] [Related]
2. Thrombospondin-1 induces differential response in human corneal and conjunctival epithelial cells lines under in vitro inflammatory and apoptotic conditions.
Soriano-Romaní L; García-Posadas L; López-García A; Paraoan L; Diebold Y
Exp Eye Res; 2015 May; 134():1-14. PubMed ID: 25753839
[TBL] [Abstract][Full Text] [Related]
3. Thrombospondins, metallo proteases and thrombospondin receptors messenger RNA and protein expression in different tumour sublines of the Dunning prostate cancer model.
Vallbo C; Damber JE
Acta Oncol; 2005; 44(3):293-8. PubMed ID: 16076702
[TBL] [Abstract][Full Text] [Related]
4. Identification of TAX2 peptide as a new unpredicted anti-cancer agent.
Jeanne A; Sick E; Devy J; Floquet N; Belloy N; Theret L; Boulagnon-Rombi C; Diebold MD; Dauchez M; Martiny L; Schneider C; Dedieu S
Oncotarget; 2015 Jul; 6(20):17981-8000. PubMed ID: 26046793
[TBL] [Abstract][Full Text] [Related]
5. Oncogenes and Angiogenesis: down-regulation of thrombospondin-1 in normal fibroblasts exposed to factors from cancer cells harboring mutant ras.
Kalas W; Yu JL; Milsom C; Rosenfeld J; Benezra R; Bornstein P; Rak J
Cancer Res; 2005 Oct; 65(19):8878-86. PubMed ID: 16204059
[TBL] [Abstract][Full Text] [Related]
6. Novel CD47-dependent intercellular adhesion modulates cell migration.
Rebres RA; Kajihara K; Brown EJ
J Cell Physiol; 2005 Nov; 205(2):182-93. PubMed ID: 15880429
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 induces apoptosis in primary leukemia and cell lines mediated by CD36 and Caspase-3.
Li K; Yang M; Yuen PM; Chik KW; Li CK; Shing MM; Lam HK; Fok TF
Int J Mol Med; 2003 Dec; 12(6):995-1001. PubMed ID: 14612980
[TBL] [Abstract][Full Text] [Related]
8. Shear stress modulates the expression of thrombospondin-1 and CD36 in endothelial cells in vitro and during shear stress-induced angiogenesis in vivo.
Bongrazio M; Da Silva-Azevedo L; Bergmann EC; Baum O; Hinz B; Pries AR; Zakrzewicz A
Int J Immunopathol Pharmacol; 2006; 19(1):35-48. PubMed ID: 16569344
[TBL] [Abstract][Full Text] [Related]
9. Escherichia coli K1 promotes the ligation of CD47 with thrombospondin-1 to prevent the maturation of dendritic cells in the pathogenesis of neonatal meningitis.
Mittal R; Gonzalez-Gomez I; Prasadarao NV
J Immunol; 2010 Sep; 185(5):2998-3006. PubMed ID: 20675593
[TBL] [Abstract][Full Text] [Related]
10. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo.
Koch M; Hussein F; Woeste A; Gründker C; Frontzek K; Emons G; Hawighorst T
Breast Cancer Res Treat; 2011 Jul; 128(2):337-46. PubMed ID: 20714802
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis.
Salajegheh M; Raju R; Schmidt J; Dalakas MC
J Neuroimmunol; 2007 Jul; 187(1-2):166-74. PubMed ID: 17572512
[TBL] [Abstract][Full Text] [Related]
12. Expression of thrombospondin-1 in prostate-derived cell lines.
Bastian M; Steiner M; Schuff-Werner P
Int J Mol Med; 2005 Jan; 15(1):49-56. PubMed ID: 15583827
[TBL] [Abstract][Full Text] [Related]
13. A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathway.
Sagawa M; Shimizu T; Fukushima N; Kinoshita Y; Ohizumi I; Uno S; Kikuchi Y; Ikeda Y; Yamada-Okabe H; Kizaki M
Cancer Sci; 2011 Jun; 102(6):1208-15. PubMed ID: 21401803
[TBL] [Abstract][Full Text] [Related]
14. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
Simantov R; Febbraio M; Silverstein RL
Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
[TBL] [Abstract][Full Text] [Related]
15. A CD36-binding peptide from thrombospondin-1 can stimulate resorption by osteoclasts in vitro.
Carron JA; Wagstaff SC; Gallagher JA; Bowler WB
Biochem Biophys Res Commun; 2000 Apr; 270(3):1124-7. PubMed ID: 10772961
[TBL] [Abstract][Full Text] [Related]
16. Exogenous thrombospondin stimulates the proliferation of non-thrombospondin-producing cells.
Yamashita Y; Sendo S; Hosokawa T; Tuszynski G; Kurohiji T; Beppu R; Shinohara T; Kinugasa T; Shirakusa T
Int J Oncol; 1998 Aug; 13(2):355-9. PubMed ID: 9664133
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD36 molecular features required for its in vitro angiostatic activity.
Primo L; Ferrandi C; Roca C; Marchiò S; di Blasio L; Alessio M; Bussolino F
FASEB J; 2005 Oct; 19(12):1713-5. PubMed ID: 16037098
[TBL] [Abstract][Full Text] [Related]
18. The role of autophagy in cytotoxicity induced by new oncogenic B-Raf inhibitor UI-152 in v-Ha-ras transformed fibroblasts.
Ahn JH; Ahn SK; Lee M
Biochem Biophys Res Commun; 2012 Jan; 417(2):857-63. PubMed ID: 22206679
[TBL] [Abstract][Full Text] [Related]
19. A TSP-1 functional fragment inhibits activation of latent transforming growth factor-beta1 derived from rat alveolar macrophage after bleomycin treatment.
Chen Y; Wang X; Weng D; Tao S; Lv L; Chen J
Exp Toxicol Pathol; 2009 Jan; 61(1):67-73. PubMed ID: 18722097
[TBL] [Abstract][Full Text] [Related]
20. An amyloid-like C-terminal domain of thrombospondin-1 displays CD47 agonist activity requiring both VVM motifs.
McDonald JF; Dimitry JM; Frazier WA
Biochemistry; 2003 Aug; 42(33):10001-11. PubMed ID: 12924949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
